[Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China].
Zhonghua Xue Ye Xue Za Zhi
; 44(7): 550-554, 2023 Jul 14.
Article
in Zh
| MEDLINE
| ID: mdl-37749033
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Follicular
/
Lymphoma, Mantle-Cell
/
Leukopenia
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Country/Region as subject:
Asia
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2023
Document type:
Article